Doctors Hospital at Renaissance 2nd Annual Obesity and Gastroenterology Summit Set for February 19th – 20th, 2016

Translate to Spanish or other 102 languages!

Mega Doctor News 

- Advertisement -

Physicians will attend interactive workshops, open-panel discussions, and question and answer sessions discussing advances in the fields of gastroenterology and obesity management 

Edinburg, TX— Doctors Hospital at Renaissance is excited to announce their 2nd Annual Obesity and Gastroenterology Summit in collaboration with Cleveland Clinic. The medical educational summit will take place at the Edinburg Conference Center at Renaissance on February 19 and 20, 2016. Faculty from Doctors Hospital at Renaissance and Cleveland Clinic will be present to share their experiences and expert opinions on the management of difficult and diverse obesity and gastrointestinal diseases.

The two-day continuing medical education conference is designed to engage physicians with other health care practitioners interested in diagnosis and management of challenging obesity cases and to expand on the latest advances in the field, including esophageal disease, liver diseases, inflammatory bowel disease, and endoscopy. The in-depth multidisciplinary sessions are also designed to engage physicians in the discussion of innovative solutions to the causes of obesity, preventative strategies, and therapeutic management approaches.

- Advertisement -

At this conference, attendees will:

  • Review guidelines for diagnosis and management of Gastroesophageal Reflux Disease, Irritable Bowel Disease, and Barrett’s disease
  • Discuss treatment options for patients with Hepatitis, Non-Alcoholic Fatty Liver Disease, and Non Alcoholic Steatohepatits
  • Discuss appropriate management of the bariatric patient
  • Design strategies that maximize the influence of lifestyle and diet therapy in weight loss maintenance
  • Review new advances in bariatric medicine and surgical intervention

Obesity and Gastroenterology Summit

Friday, February 19 and Saturday, February 20, 2016 / 3:00 PM registration on Friday

Edinburg Conference Center at Renaissance

- Advertisement -

118 Paseo Del Prado, Edinburg, TX 78539

Register online at : https://bit.ly/obesitysummit2016

For more information about the 2nd Annual Obesity and Gastroenterology Summit, please call the Doctors Hospital at Renaissance Continuing Medical Education Department at 956-362-3242 or email a.badillo@dhr-rgv.com.

Doctors Hospital at Renaissance is accredited by the Texas Medical Association to provide continuing medical education for physicians. Doctors Hospital at Renaissance designates this live educational activity for a maximum of 12 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation of the activity.

Doctors Hospital at Renaissance is an approved provider of continuing nursing education by the Texas Nurses Association, an accredited approver by the American Nurse Credentialing Center’s Commission on Accreditation. Doctors Hospital at Renaissance provides up to 12 contact hours for successful completion of this educational activity.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Embolism Treatment Developed at University of Michigan receives FDA clearance 

Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated. 

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.
- Advertisement -